Form 4: Biostem Technologies CEO Reports Stock Transaction
Insider Transaction (Form 4)
Jason Matuszewski, Chief Executive Officer, a Director and 10% owner of Biostem Technologies, reported multiple transactions in common stock on October 7, 2026.
Summary
- Option exercise/conversion: acquired 250,000 Common Stock at $2.00 ($500,000) on October 7, 2026; holds 1,553,551 after (Direct).
- Option exercise/conversion: disposed of 250,000 Options (Right to Buy) on October 7, 2026; holds 2,000,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jason Matuszewski — Director, Officer (Chief Executive Officer), 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-07 | Option exercise/conversion | Common Stock | 250,000 | $2 | $500.0K | 1,553,551 |
| 2026-10-07 | Option exercise/conversion | Options (Right to Buy) | 250,000 | — | — | 2,000,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-07 | Option exercise/conversion (250,000 shares) |
| 2026-10-07 | Option exercise/conversion (250,000 shares) |
Keywords
insider transaction, Form 4, BSEM, BioStem Technologies, Inc., neutral, Jason Matuszewski
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.